Search hospitals > New York > Stony Brook
Stony Brook Cancer Center
Claim this profileStony Brook, New York 11794
Global Leader in Cancer
Conducts research for Leukemia
Conducts research for Bladder Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
58 reported clinical trials
7 medical researchers
Summary
Stony Brook Cancer Center is a medical facility located in Stony Brook, New York. This center is recognized for care of Cancer, Leukemia, Bladder Cancer, Lung Cancer, Lymphoma and other specialties. Stony Brook Cancer Center is involved with conducting 58 clinical trials across 107 conditions. There are 7 research doctors associated with this hospital, such as Minsig Choi, Amna Sher, Roger S. Keresztes, and Lea Baer, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Leukemia
KMT2A positive
NPM1 positive
FLT3 positive
Top PIs
Minsig ChoiStony Brook Cancer Center5 years of reported clinical research
Studies Colorectal Cancer
Studies Stomach Cancer
10 reported clinical trials
20 drugs studied
Amna SherStony Brook University Medical Center3 years of reported clinical research
Studies Cancer
Studies Lung Cancer
9 reported clinical trials
14 drugs studied
Roger S. KeresztesStony Brook University Medical Center10 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
8 reported clinical trials
17 drugs studied
Lea Baer, MDStony Brook University Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Cancer
8 reported clinical trials
23 drugs studied
Clinical Trials running at Stony Brook Cancer Center
Acute Myeloid Leukemia
Ovarian Cancer
Leukemia
Cancer
Acute Leukemia
Gallbladder Cancer
Bile Duct Cancer
Myeloid Leukemia
NPM1 Mutation
Kabuki Syndrome
Ziftomenib Combinations
for Acute Myeloid Leukemia
This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azacitidine (ven/aza), ven, and 7+3 for two different molecularly-defined arms, NPM1-m and KMT2A-r.
Recruiting1 award Phase 1
Ziftomenib Combinations
for Acute Myeloid Leukemia
The safety, tolerability, and antileukemic response of ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia will be examined with the following agents: FLAG-IDA, low-dose cytarabine, and gilteritinib.
Recruiting1 award Phase 19 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Stony Brook Cancer Center?
Stony Brook Cancer Center is a medical facility located in Stony Brook, New York. This center is recognized for care of Cancer, Leukemia, Bladder Cancer, Lung Cancer, Lymphoma and other specialties. Stony Brook Cancer Center is involved with conducting 58 clinical trials across 107 conditions. There are 7 research doctors associated with this hospital, such as Minsig Choi, Amna Sher, Roger S. Keresztes, and Lea Baer, MD.